Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' LUCCHESI BR' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 130 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Fischbach, PS; Barrett, TD; Goyal, R; Tran, BC; Syed, ZA; Hennan, JK; Lucchesi, BR
      Conversion of atrial fibrillation by the experimental antiarrhythmic drug tedisamil in two canine models

      JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
    2. Hasan, AAK; Schmaier, AH; Warnock, MA; Normolle, D; Driscoll, E; Lucchesi, BR; Werns, SW
      Thrombostatin inhibits cyclic flow variations in stenosed canine coronary arteries

      THROMBOSIS AND HAEMOSTASIS
    3. Patel, MB; Kilgore, KS; Ortolano, GA; Gryboski, CL; Qureshi, MA; Marcovitz, P; Naylor, KB; Park, JL; Wenz, B; Gikakis, N; Freedman, RJ; Lucchesi, BR; O'Neill, WW
      Conditioned blood reperfusion during angioplasty (CoBRA) treatment of acute myocardial infarction

      PERFUSION-UK
    4. Huang, JB; Feldbaum, VM; Lucchesi, BR; Werns, SW
      Effects of adenosine on thrombosis and thrombolysis in a canine experimental preparation

      PHARMACOLOGY
    5. Hennan, JK; Huang, JB; Barrett, TD; Driscoll, EM; Willens, DE; Park, AM; Crofford, LJ; Lucchesi, BR
      Effects of selective cyclooxygenase-2 inhibition on vascular responses andthrombosis in canine coronary arteries

      CIRCULATION
    6. Barrett, TD; Hennan, JK; Fischbach, PS; O'Neill, BP; Driscoll, EM; Lucchesi, BR
      Tedisamil and dofetilide-induced torsades de pointes, rate and potassium dependence

      BRITISH JOURNAL OF PHARMACOLOGY
    7. Tanhehco, EJ; Lucchesi, BR
      Therapeutic potential of complement inhibitors in myocardial ischaemia

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    8. Rebello, SS; Huang, J; Faul, JD; Lucchesi, BR
      Role of extracellular ionized calcium in the in vitro assessment of GPIIb/IIIa receptor antagonists

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    9. Tanhehco, EJ; Yasojima, K; McGeer, PL; McGeer, EG; Lucchesi, BR
      Preconditioning reduces myocardial complement gene expression in vivo

      AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
    10. Tanhehco, EJ; Yasojima, K; McGeer, PL; Washington, RA; Lucchesi, BR
      Free radicals upregulate complement expression in rabbit isolated heart

      AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
    11. Tanhehco, EJ; Lee, HY; Lucchesi, BR
      Sublytic complement attack reduces infarct size in rabbit isolated hearts:evidence for C5a-mediated cardioprotection

      IMMUNOPHARMACOLOGY
    12. Rebello, SS; Blank, HS; Lucchesi, BR
      Antithrombotic efficacy of single subcutaneous administration of a recombinant nematode anticoagulant peptide (rNAP5) in a canine model of coronary artery thrombolysis

      THROMBOSIS RESEARCH
    13. Huang, JB; Driscoll, EM; Gonzales, ML; Park, AM; Lucchesi, BR
      Prevention of arterial thrombosis by intravenously administered platelet P2T receptor antagonist AR-C69931MX in a canine model

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    14. Tanhehco, EJ; Yasojima, K; McGeer, PL; Lucchesi, BR
      Acute cocaine exposure up-regulates complement expression in rabbit heart

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    15. Kilgore, KS; Lucchesi, BR
      Neutrophils and altered myocardial function

      AMERICAN HEART JOURNAL
    16. Tanhehco, EJ; Yasojima, K; McGeer, PL; Washington, RA; Kilgore, KS; Homeister, JW; Lucchesi, BR
      Preconditioning reduces tissue complement gene expression in the rabbit isolated heart

      AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
    17. Hasan, AAK; Rebello, SS; Smith, E; Srikanth, S; Werns, S; Driscoll, E; Faul, J; Brenner, D; Normolle, D; Lucchesi, BR; Schmaier, AH
      Thrombostatin inhibits induced canine coronary thrombosis

      THROMBOSIS AND HAEMOSTASIS
    18. Fischbach, PS; Johnston, PV; Friedrichs, GS; Lucchesi, BR
      Tedisamil in a chronic canine model of atrial flutter

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    19. Tanhehco, EJ; Kilgore, KS; Naylor, KB; Park, JL; Booth, EA; Lucchesi, BR
      Reduction of myocardial infarct size after ischemia and reperfusion by theglycosaminoglycan pentosan polysulfate

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    20. Chi, L; Rebello, S; Lucchesi, BR
      In vivo models of thrombosis

      ANTITHROMBOTICS
    21. Tanhehco, EJ; Kilgore, KS; Liff, DA; Murphy, KL; Fung, MS; Sun, WN; Sun, C; Lucchesi, BR
      The anti-factor D antibody, MAb 166-32, inhibits the alternative pathway of the human complement system

      TRANSPLANTATION PROCEEDINGS
    22. Huang, JB; Rebello, SS; Faul, JD; Lucchesi, BR
      Correlation between the in vivo efficacy of GPIIb/IIIa receptor antagonists (m7E3, MK-383 and DMP-728) and ex vivo platelet inhibition

      PHARMACOLOGY
    23. Park, JL; Kilgore, KS; Naylor, KB; Booth, EA; Murphy, KL; Lucchesi, BR
      N-acetylheparin pretreatment reduces infarct size in the rabbit

      PHARMACOLOGY
    24. Schwartz, CF; Kilgore, KS; Homeister, JW; Levy, BA; Lucchesi, BR; Bolling, SF
      Increased rat cardiac allograft survival by the glycosaminoglycan pentosanpolysulfate

      JOURNAL OF SURGICAL RESEARCH
    25. Kilgore, KS; Tanhehgo, EJ; Naylor, KB; Lucchesi, BR
      Ex vivo reversal of heparin-mediated cardioprotection by heparinase after ischemia and reperfusion

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    26. Rebello, SS; Huang, JB; Saito, K; Saucedo, JF; Bates, ER; Lucchesi, BR
      Effect of time of 7E3 administration on rt-PA-induced reperfusion: study in a canine model of thrombus-based occlusion-reperfusion

      EUROPEAN JOURNAL OF PHARMACOLOGY
    27. Huang, JB; Rebello, SS; Rosenberg, LA; Kaneko, M; Sakurama, T; Lucchesi, BR
      Temporary and partial inhibition of platelets by SM-20302 prevents coronary artery thrombosis in a chronic canine model

      EUROPEAN JOURNAL OF PHARMACOLOGY
    28. Park, JL; Lucchesi, BR
      Mechanisms of myocardial reperfusion injury

      ANNALS OF THORACIC SURGERY
    29. REBELLO SS; HUANG JB; SAITO K; LUCCHESI BR
      IN-VIVO EFFICACY OF SM-20302, A GP IIB IIIA RECEPTOR ANTAGONIST, CORRELATES WITH EX-VIVO PLATELET INHIBITION IN HEPARINIZED BLOOD BUT NOT IN CITRATED BLOOD/

      Arteriosclerosis, thrombosis, and vascular biology
    30. KILGORE KS; MCGEER PL; YAGOSHIMA K; WASHINGTON RA; NAYLOR KB; LUCCHESI BR
      MYOCARDIAL EXPRESSION OF THE MESSENGER-RNAS ENCODING COMPLEMENT PROTEINS C3 AND C9 AFTER ISCHEMIA REPERFUSION EX-VIVO/

      The FASEB journal
    31. TANHEHCO EJ; KILGORE KS; NAYLOR KB; LUCCHESI BR
      EX-VIVO REVERSAL OF HEPARIN-MEDIATED CARDIOPROTECTION BY HEPARANASE AFTER ISCHEMIA AND REPERFUSION

      The FASEB journal
    32. HUANG J; REBELLO SS; FAUL JD; LUCCHESI BR
      CORRELATION BETWEEN THE IN-VIVO EFFICACY OF GPIIB IIIA RECEPTOR ANTAGONISTS AND EX-VIVO PLATELET INHIBITION - ROLE OF CALCIUM/

      The FASEB journal
    33. WASHINGTON RA; KILGORE KS; MURPHY K; LITTLETON JM; BOOTH EA; LUCCHESI BR
      ANALYSIS OF HEPARINS CARDIOPROTECTIVE EFFECTS IN-VITRO

      The FASEB journal
    34. REBELLO SS; HUANG JB; SHIN WJ; SAITO K; KANEKO M; SAITOH Y; LUCCHESI BR
      PHARMACOKINETICS AND PHARMACODYNAMICS OF SM-20302, A GPIIB IIIA RECEPTOR ANTAGONIST, IN ANESTHETIZED DOGS/

      Journal of cardiovascular pharmacology
    35. FRIEDRICHS GS; ABREU JN; DRISCOLL EM; BORLAK J; LUCCHESI BR
      ANTIFIBRILLATORY EFFICACY OF LONG-TERM TEDISAMIL ADMINISTRATION IN A POSTINFARCTED CANINE MODEL OF ISCHEMIC VENTRICULAR-FIBRILLATION

      Journal of cardiovascular pharmacology
    36. BLACK SC; DRISCOLL EM; LUCCHESI BR
      EFFECT OF RAMIPRILAT OR CAPTOPRIL ON MYOCARDIAL INFARCT SIZE - ASSESSMENT IN CANINE MODELS OF ISCHEMIA ALONE AND ISCHEMIA WITH REPERFUSION

      Pharmacology
    37. KILGORE KS; NAYLOR KB; TANHEHCO EJ; PARK JL; BOOTH EA; WASHINGTON RA; LUCCHESI BR
      THE SEMISYNTHETIC POLYSACCHARIDE PENTOSAN POLYSULFATE PREVENTS COMPLEMENT-MEDIATED MYOCARDIAL INJURY IN THE RABBIT PERFUSED HEART

      The Journal of pharmacology and experimental therapeutics
    38. KILGORE KS; TANHEHCO EJ; PARK JL; NAYLOR KB; ANDERSON MB; LUCCHESI BR
      REDUCTION OF MYOCARDIAL INFARCT SIZE IN-VIVO BY CARBOHYDRATE-BASED GLYCOMIMETICS

      The Journal of pharmacology and experimental therapeutics
    39. KILGORE KS; PARK JL; TANHEHCO EJ; BOOTH EA; MARKS RM; LUCCHESI BR
      ATTENUATION OF INTERLEUKIN-8 EXPRESSION IN C6-DEFICIENT RABBITS AFTERMYOCARDIAL ISCHEMIA REPERFUSION/

      Journal of Molecular and Cellular Cardiology
    40. YASOJIMA K; KILGORE KS; WASHINGTON RA; LUCCHESI BR; MCGEER PL
      COMPLEMENT GENE-EXPRESSION BY RABBIT HEART - UP-REGULATION BY ISCHEMIA AND REPERFUSION

      Circulation research
    41. ANNICH G; WHITE T; DAMM D; ZHAO YQ; FAKHRI M; MEINHARDT J; REBELLO S; LUCCHESI BR; BARTLETT RH; SCHMAIER AH
      RECOMBINANT KUNITZ PROTEASE INHIBITOR DOMAIN OF THE AMYLOID BETA-PROTEIN PRECURSOR AS AN ANTICOAGULANT FOR EXTRACORPOREAL-CIRCULATION IN RABBITS

      Circulation
    42. LUCCHESI BR; KILGORE KS
      COMPLEMENT INHIBITORS IN MYOCARDIAL ISCHEMIA REPERFUSION INJURY/

      Immunopharmacology
    43. PARK JL; TANHEHCO EJ; KILGORE KS; GRALINSKI MR; LUCCHESI BR
      REVIPARIN-SODIUM PREVENTS COMPLEMENT-MEDIATED MYOCARDIAL INJURY IN THE ISOLATED RABBIT HEART

      Journal of cardiovascular pharmacology
    44. REBELLO SS; MILLER BV; BASLER GC; LUCCHESI BR
      CVS-1123, A DIRECT THROMBIN INHIBITOR, PREVENTS OCCLUSIVE ARTERIAL AND VENOUS THROMBOSIS IN A CANINE MODEL OF VASCULAR INJURY

      Journal of cardiovascular pharmacology
    45. REBELLO SS; DRISCOLL EM; LUCCHESI BR
      TP-9201, A GLYCOPROTEIN IIB IIIA PLATELET RECEPTOR ANTAGONIST, PREVENTS RETHROMBOSIS AFTER SUCCESSFUL ARTERIAL THROMBOLYSIS IN THE DOG/

      Stroke
    46. MOUSA SA; MU DX; LUCCHESI BR
      PREVENTION OF CAROTID-ARTERY THROMBOSIS BY ORAL PLATELET GPIIB IIIA ANTAGONIST IN DOGS/

      Stroke
    47. REBELLO SS; BLANK HS; ROTE WE; VLASUK GP; LUCCHESI BR
      ANTITHROMBOTIC EFFICACY OF A RECOMBINANT NEMATODE ANTICOAGULANT PEPTIDE (RNAP5) IN CANINE MODELS OF THROMBOSIS AFTER SINGLE SUBCUTANEOUS ADMINISTRATION

      The Journal of pharmacology and experimental therapeutics
    48. GRALINSKI MR; PARK JL; OZECK MA; WIATER BC; LUCCHESI BR
      LU-51198, A HIGHLY SULFATED, LOW-MOLECULAR-WEIGHT HEPARIN DERIVATIVE,PREVENTS COMPLEMENT-MEDIATED MYOCARDIAL INJURY IN THE PERFUSED RABBITHEART

      The Journal of pharmacology and experimental therapeutics
    49. FRIEDRICHS CS; ABREU JN; COUSINS GR; KERRICK GP; CHI L; LUCCHESI BR
      TEDISAMIL PROTECTS AGAINST VENTRICULAR-FIBRILLATION IN A CONSCIOUS CANINE MODEL OF SUDDEN CARDIAC DEATH

      The FASEB journal
    50. GRALINSKI MR; WIATER BC; ASSENMACHER AN; OZECK MJ; LUCCHESI BR
      SELECTIVE-INHIBITION OF THE ALTERNATIVE COMPLEMENT PATHWAY BY SCR1[DESLHR-A] PROTECTS THE ISOLATED RABBIT HEART FROM HUMAN COMPLEMENT-MEDIATED DAMAGE

      The FASEB journal
    51. OZECK MJ; GRALINSKI MR; PARK JL; LUCCHESI BR
      A SULFATED FRACTION OF HEPARIN INHIBITS HUMAN COMPLEMENT-MEDIATED DAMAGE OF THE EX-VIVO DISCORDANT MYOCARDIAL XENOGRAFT

      The FASEB journal
    52. PARK JL; GRALINSKI MR; PEREZ M; LUCCHESI BR
      EFFECTS OF LOW-MOLECULAR-WEIGHT HEPARIN ON COMPLEMENT-MEDIATED INJURYIN THE RABBIT ISOLATED HEART

      The FASEB journal
    53. BASLER GC; MILLER BV; REBELLO S; LUCCHESI BR
      SYNTHETIC THROMBIN INHIBITOR CVS-1123 INHIBITS VENOUS AND ARTERIAL THROMBOSIS IN THE ACUTE CANINE MODEL

      The FASEB journal
    54. REBELLO SS; LUCCHESI BR
      SIGNIFICANCE OF FACTOR XA INHIBITION IN A CANINE MODEL OF CORONARY-THROMBOSIS - EFFECTS OF RECOMBINANT NEMATODE ANTICOAGULANT PEPTIDE (RNAP5)

      The FASEB journal
    55. GRALINSKI MR; BLACK SC; STANCATO LF; KILGORE KS; CAMPAU PA; PARK JL; OZECK MJ; PRATT WB; LUCCHESI BR
      HEAT-STRESS PROTECTS THE PERFUSED RABBIT HEART FROM COMPLEMENT-MEDIATED INJURY

      American journal of physiology. Heart and circulatory physiology
    56. GRALINSKI MR; WIATER BC; ASSENMACHER AN; LUCCHESI BR
      SELECTIVE-INHIBITION OF THE ALTERNATIVE COMPLEMENT PATHWAY BY SCR1[DESLHR-A] PROTECTS THE RABBIT ISOLATED HEART FROM HUMAN COMPLEMENT-MEDIATED DAMAGE

      Immunopharmacology
    57. SUDO YJ; LUCCHESI BR
      ANTITHROMBOTIC EFFECT OF GYKI-14766 IN A CANINE MODEL OF ARTERIAL ANDVENOUS RETHROMBOSIS - A COMPARISON WITH HEPARIN

      Journal of cardiovascular pharmacology
    58. FRIEDRICHS GS; ABREU JN; BLACK SC; CHI LG; LUCCHESI BR
      5-HYDROXYDECANOATE FAILS TO ATTENUATE VENTRICULAR-FIBRILLATION IN A CONSCIOUS CANINE MODEL OF SUDDEN CARDIAC DEATH

      European journal of pharmacology
    59. HASAN AA; REBELLO SS; WAHL R; FISHER SJ; LUCCHESI BR; SCHMAIER AH
      THROMBOSTATIN - IN-VIVO CLEARANCE AND EFFECT OF THIS THROMBIN RECEPTOR INHIBITOR

      Circulation
    60. REBELLO SS; LUCCHESI BR
      RECOMBINANT NEMATODE ANTICOAGULANT PEPTIDE (RNAP5), A SELECTIVE FACTOR XA INHIBITOR, PREVENTS CANINE CORONARY-ARTERY THROMBOSIS

      Circulation
    61. COUSINS GR; FRIEDRICHS GS; SUDO Y; REBELLO SS; ROTE WE; VLASUK GP; NOLAN TG; MENDOZA C; LUCCHESI BR
      ORALLY EFFECTIVE CVS-1123 PREVENTS CORONARY-ARTERY THROMBOSIS IN THE CONSCIOUS DOG

      Circulation
    62. MOUSA SA; DEGRADO WF; MU DX; KAPIL RP; LUCCHESI BR; REILLY TM
      ORAL ANTIPLATELET, ANTITHROMBOTIC EFFICACY OF DMP-728, A NOVEL PLATELET GPIIB IIIA ANTAGONIST/

      Circulation
    63. CHI LG; PARK JL; FRIEDRICHS GS; BANGLAWALA YA; PEREZ MA; TANHEHCO EJ; LUCCHESI BR
      EFFECTS OF TEDISAMIL (KC-8857) ON CARDIAC ELECTROPHYSIOLOGY AND VENTRICULAR-FIBRILLATION IN THE RABBIT ISOLATED HEART

      British Journal of Pharmacology
    64. MOUSA SA; BOZARTH JM; MU DX; LEAMY AW; ROTE WE; LUCCHESI BR; REILLY TM
      INTRAVENOUS AND ORAL ANTITHROMBOTIC EFFICACY OF THE PLATELET GPIIB IIIA ANTAGONIST, DMP728, IN DIFFERENT MODELS OF ARTERIAL THROMBOSIS/

      The FASEB journal
    65. REILLY TM; FORSYTHE MS; LUCCHESI BR; MOUSA SA
      THROMBOLYTIC AND ANTITHROMBOTIC EFFICACY OF THE PLATELET GPIIB IIIA ANTAGONIST DMP728/

      The FASEB journal
    66. COUSINS GR; SUDO Y; FRIEDRICHS GS; MARKLAND FM; LUCCHESI BR
      CONTORTROSTATIN PREVENTS REOCCLUSION AFTER THROMBOLYTIC THERAPY IN A CANINE MODEL OF CAROTID-ARTERY THROMBOSIS

      The FASEB journal
    67. PARK JL; KILGORE KS; MUSSER JH; LUCCHESI BR
      REDUCTION OF MYOCARDIAL INFARCT SIZE IN THE RABBIT BY A CARBOHYDRATE ANALOG OF SIALYL LEWIS(X)

      The FASEB journal
    68. GRALINSKI MR; FRIEDRICHS GS; DRISCOLL EM; LUCCHESI BR
      EFFECTS OF A SINGLE ADMINISTRATION OF HEPARIN OR N-ACETYLHEPARIN (NHEP) 2 HOURS BEFORE REGIONAL ISCHEMIA AND REPERFUSION IN A CANINE MODEL OF IRREVERSIBLE MYOCARDIAL INJURY

      The FASEB journal
    69. CHI LG; FRIEDRICHS GS; PARK JL; BANGLAWALA YA; PEREZ MA; TANHEHCO EJ; LAN KL; LUCCHESI BR
      EFFECTS OF TEDISAMIL (KC-8857) ON ELECTROPHYSIOLOGY, VENTRICULAR-FIBRILLATION (VF) AND CARDIAC-FUNCTION IN-VITRO

      The FASEB journal
    70. FRIEDRICHS GS; BLACK SC; CHI L; MU DX; PEWITT SR; LUCCHESI BR
      THE KATP CHANNEL ANTAGONIST 5-HYDROXYDECANOATE FAILS TO PROTECT AGAINST VENTRICULAR-FIBRILLATION IN A CONSCIOUS CANINE MODEL OF SUDDEN CARDIAC DEATH

      The FASEB journal
    71. MOUSA SA; MU DX; FORSYTHE M; LUCCHESI BR; REILLY TM
      ANTITHROMBOTIC AND THROMBOLYTIC EFFICACY OF THE PLATELET GPIIB IIIA ANTAGONIST DMP-728 IN ARTERIAL THROMBOSIS RETHROMBOSIS MODELS/

      Thrombosis and haemostasis
    72. MARKLAND FS; TRIKHA M; SUDO Y; FRIEDRICHS GS; COUSINS GR; LUCCHESI BR
      CONTORTROSTATIN, A DISINTEGRIN WITH POTENT ANTIPLATELET ACTIVITY, PREVENTS REOCCLUSION FOLLOWING THROMBOLYSIS IN A CANINE CAROTID-ARTERY THROMBOSIS MODEL

      Thrombosis and haemostasis
    73. MINAMI M; DRISCOLL E; LUCCHESI BR
      ANTITHROMBOTIC AND CARDIOVASCULAR EFFECTS OF BMY-20844, AN INHIBITOR OF CAMP-PHOSPHODIESTERASE, IN A CANINE MODEL OF CORONARY-ARTERY THROMBOSIS

      Biogenic amines
    74. SUDO Y; KILGORE KS; LUCCHESI BR
      MONOCLONAL-ANTIBODY [7E3 F(AB')(2)] PREVENTS ARTERIAL BUT NOT VENOUS RETHROMBOSIS

      Journal of cardiovascular pharmacology
    75. FRIEDRICHS GS; CHI L; GRALINSKI MR; BLACK SC; BASLER GC; MU DX; PEWITT SR; JOHNSON CR; LUCCHESI BR
      MS-551 PROTECTS AGAINST VENTRICULAR-FIBRILLATION IN A CHRONIC CANINE MODEL OF SUDDEN CARDIAC DEATH

      Journal of cardiovascular pharmacology
    76. MINAMI M; DRISCOLL EM; SIMPSON PJ; HOFF PT; LUCCHESI BR
      EFFECTS OF BMY21190, AN INHIBITOR OF CAMP-PHOSPHODIESTERASE, ON INFARCT SIZE AND MYELOPEROXIDASE ACTIVITY IN THE ISCHEMIC MYOCARDIUM OF A CANINE OCCLUSION-REPERFUSION MODEL

      Pharmacology
    77. VIRKHAUS R; LUCCHESI BR; SIMPSON PJ; SHEBUSKI RJ
      THE ROLE OF ADHESION MOLECULES IN CARDIOVASCULAR PHARMACOLOGY - MEETING REVIEW

      The Journal of pharmacology and experimental therapeutics
    78. COUSINS GR; FRIEDRICHS GS; SUDO YJ; ROTE WE; VLASUK GP; NOLAN T; MENDOZA C; LUCCHESI BR
      ORALLY EFFECTIVE CVS-1123 PREVENTS CORONARY-ARTERY THROMBOSIS IN THE CONSCIOUS CANINE

      Circulation
    79. GRALINSKI MR; PARK JL; EZRIN AM; LUCCHESI BR
      O-DESULFATED HEPARIN PREVENTS COMPLEMENT-MEDIATED INJURY IN THE EX-VIVO RABBIT HEART

      Circulation
    80. BLACK SC; GRALINSKI MR; FRIEDRICHS GS; KILGORE KS; DRISCOLL E; LUCCHESI BR
      CARDIOPROTECTIVE EFFECTS OF HEPARIN OR N-ACETYLHEPARIN IN AN IN-VIVO MODEL OF MYOCARDIAL ISCHEMIC AND REPERFUSION INJURY

      Cardiovascular Research
    81. ROTE WF; DAVIS JH; MOUSA SA; REILLY TM; LUCCHESI BR
      ANTITHROMBOTIC EFFECTS OF DMP728, A FIBRINOGEN RECEPTOR (PLATELET GPIIB IIIA) ANTAGONIST/

      The FASEB journal
    82. CHI L; KHANUJA NK; FRIEDRICHS GS; GREEN AL; LUCCHESI BR
      CATECHOLAMINE DEPENDENT EFFECT OF ADENOSINE-INDUCED VENTRICULAR-FIBRILLATION IN THE RABBIT ISOLATED HEART

      The FASEB journal
    83. FRIEDRICHS GS; CHI L; GRALINSKI MR; JOHNSON CR; BASLER GC; MU DX; PEWITT SR; LUCCHESI BR
      VENTRICULAR-FIBRILLATION IN A CONSCIOUS CANINE MODEL OF SUDDEN CARDIAC DEATH - EFFECTS OF MS-551, A MULTIPLE-DOSE REGIMEN

      The FASEB journal
    84. GREEN AL; FRIEDRICHS GS; CHI L; LUCCHESI BR
      ANTIFIBRILLATORY EFFECTS OF CLOFILIUM IN THE RABBIT ISOLATED HEART

      The FASEB journal
    85. LUCCHESI BR; FRIEDRICHS GS; KILGORE KS; MANLEY PJ
      EFFECTS OF HEPARIN AND N-ACETYLHEPARIN ON ISCHEMIA-REPERFUSION INDUCED ALTERATIONS IN MYOCARDIAL-FUNCTION IN THE RABBIT ISOLATED HEART

      The FASEB journal
    86. CAMPAU PA; KILGORE KS; LUCCHESI BR
      COMPLEMENT-MEDIATED NEUTROPHIL ADHESION IN THE RABBIT ISOLATED HEART

      The FASEB journal
    87. KILGORE KS; GRALINSKI MR; LUCCHESI BR
      EFFECT OF COMPLEMENT ACTIVATION ON NEUTROPHIL-MEDIATED INJURY IN THE RABBIT ISOLATED HEART

      The FASEB journal
    88. GRALINSKI MR; BLACK SC; KILGORE KS; CHOU AY; DENARDIS M; LUCCHESI BR
      CARDIOPROTECTIVE EFFECTS OF RANOLAZINE (RS-43285) ON ISOLATED RABBIT HEARTS DURING ISCHEMIA-REPERFUSION

      The FASEB journal
    89. BLACK SC; GRALINSKI MR; FRIEDRICHS GS; KILGORE KS; DRISCOLL EM; LUCCHESI BR
      CARDIOPROTECTIVE EFFECTS OF N-ACETYLHEPARIN (NHEP) IN A CANINE MODEL OF ISCHEMIA AND REPERFUSION INJURY

      The FASEB journal
    90. CHI LG; FRIEDRICHS GS; OH JY; GREEN AL; LUCCHESI BR
      EFFECT OF ADO A(1)-RECEPTOR AND A(2)-RECEPTOR ACTIVATION ON VENTRICULAR-FIBRILLATION DURING HYPOXIA-REOXYGENATION

      American journal of physiology. Heart and circulatory physiology
    91. HOMEISTER JW; LUCCHESI BR
      COMPLEMENT ACTIVATION AND INHIBITION IN MYOCARDIAL-ISCHEMIA AND REPERFUSION INJURY

      Annual review of pharmacology and toxicology
    92. BLACK SC; GRALINSKI MR; MCCORMACK JG; DRISCOLL EM; LUCCHESI BR
      EFFECT OF RANOLAZINE ON INFARCT SIZE IN A CANINE MODEL OF REGIONAL MYOCARDIAL ISCHEMIA REPERFUSION/

      Journal of cardiovascular pharmacology
    93. ROTE WE; DAVIS JH; MOUSA SA; REILLY TM; LUCCHESI BR
      ANTITHROMBOTIC EFFECTS OF DMP-728, A PLATELET GPIIB IIIA RECEPTOR ANTAGONIST, IN A CANINE MODEL OF ARTERIAL THROMBOSIS/

      Journal of cardiovascular pharmacology
    94. ROTE WE; MU DX; BATES ER; NEDELMAN MA; LUCCHESI BR
      PREVENTION OF RETHROMBOSIS AFTER CORONARY THROMBOLYSIS IN A CHRONIC CANINE MODEL .1. ADJUNCTIVE THERAPY WITH MONOCLONAL-ANTIBODY 7E3 F(AB')(2) FRAGMENT

      Journal of cardiovascular pharmacology
    95. ROTE WE; MU DX; BATES ER; NEDELMAN MA; LUCCHESI BR
      PREVENTION OF RETHROMBOSIS AFTER CORONARY THROMBOLYSIS IN A CHRONIC CANINE MODEL .2. ADJUNCTIVE THERAPY WITH R-HIRUDIN

      Journal of cardiovascular pharmacology
    96. FRIEDRICHS GS; CHI LG; BLACK SC; MANLEY PJ; LUCCHESI BR
      ANTIARRHYTHMIC AGENT, MS-551, PROTECTS AGAINST PINACIDIL PLUS HYPOXIA-INDUCED VENTRICULAR-FIBRILLATION IN LANGENDORFF-PERFUSED RABBIT ISOLATED HEART

      Journal of cardiovascular pharmacology
    97. TRIKHA M; ROTE WE; MANLEY PJ; LUCCHESI BR; MARKLAND FS
      PURIFICATION AND CHARACTERIZATION OF PLATELET-AGGREGATION INHIBITORS FROM SNARE VENOMS

      Thrombosis research
    98. ROTE WE; NEDELMAN MA; MU DX; MANLEY PJ; WEISMAN H; CUNNINGHAM MR; LUCCHESI BR
      CHIMERIC 7E3 PREVENTS CAROTID-ARTERY THROMBOSIS IN CYNOMOLGUS MONKEYS

      Stroke
    99. BLACK SC; SCHASTEEN CS; WEISS RH; RILEY DP; DRISCOLL EM; LUCCHESI BR
      INHIBITION OF IN-VIVO MYOCARDIAL ISCHEMIC AND REPERFUSION INJURY BY ASYNTHETIC MANGANESE-BASED SUPEROXIDE-DISMUTASE MIMETIC

      The Journal of pharmacology and experimental therapeutics
    100. KILGORE KS; FRIEDRICHS GS; JOHNSON CR; SCHASTEEN CS; RILEY DP; WEISS RH; RYAN U; LUCCHESI BR
      PROTECTIVE EFFECTS OF THE SOD-MIMETIC SC-52608 AGAINST ISCHEMIA REPERFUSION DAMAGE IN THE RABBIT ISOLATED HEART/

      Journal of Molecular and Cellular Cardiology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/01/21 alle ore 12:07:04